Showing results (301-310 of 2,330) with videos related to

Sort By:
Pageof 233
Clinical Drug Investigation|July 14, 2009
Criterion validity of the ARthritis Treatment Satisfaction (ARTS) questionnaire: patient satisfaction with treatment and need for switching therapyJavier Rejas, Jordi Monfort, Miguel A Campillo, et al.
Clinical Drug Investigation|December 6, 2013
Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcomaFrancesca Ingegnoli, Athanasia Tourlaki, Roberta Gualtierotti
Clinical Drug Investigation|November 12, 2013
Cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin D for management of secondary hyperparathyroidism in haemodialysis patients in the USAAmit Sharma, Thomas S Marshall, Samina S Khan, et al.
Clinical Drug Investigation|October 12, 2013
Short-term impact of low-dose atorvastatin on serum proprotein convertase subtilisin/kexin type 9Yuan-Lin Guo, Jun Liu, Rui-Xia Xu, et al.
Clinical Drug Investigation|October 16, 2013
Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA studyAmparo Santamaría, Arantxa Ugarriza, Carmen Muñoz, et al.
Clinical Drug Investigation|September 7, 2007
Age and gender biases in secondary prevention of coronary heart disease in a Finnish university hospital settingSanna-Maria Michou, Mika Kähönen, Terho Lehtimäki, et al.
Clinical Drug Investigation|September 7, 2007
Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study designAndreas Goette, Günter Breithardt, Thomas Fetsch, et al.
Clinical Drug Investigation|September 7, 2007
Decreased serum glucose levels after initiation of methylphenidate in a patient status post-cerebellar tumour resection: a potential interaction with glipizideSamuel T Gontkovsky, Robert Nevels, Nicholas B McDonald, et al.
Clinical Drug Investigation|May 11, 2010
Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centreClementina Stimolo, Valentina Del Favero, Giancarlo Zecchinato, et al.
Clinical Drug Investigation|June 10, 2010
Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled studyHåkan Walfridsson, Birgitta Johansson, Anders Englund, et al.
Pageof 233